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Background: Cartilage-hair hypoplasia (MIM 250250) is an autosomal recessive 
disease with diverse clinical manifestations. The clinical phenotypes include variable 
degrees of bone and hair dysplasia, deficient cellular and/or humoral immunity, 
and a predisposition to malignancy.
Methods: We performed genetic studies of a patient with disproportionate short 
stature and brittle scalp hair. Genetic studies were also carried out in the patient’s 
parents.
Results: A novel maternal mutation that consisted of a duplication of 14 nucle-
otides at position −13 of the RNA component of the RNA component of mitochondrial 
RNA processing endoribonuclease gene (RMRP; g. −26 to −13 dupTACTACTCTGTGAA, pro-
moter region) and a paternal mutation base substitution of C to T at nucleotide + 230 
(designated as + 1 in the transcription initiation site) in the coding sequence of RMRP were 
detected in this patient.
Conclusion: A novel maternal RMRP mutation was found in a Chinese boy with typical 
cartilage-hair hypoplasia.
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1.  Introduction
Cartilage-hair hypoplasia (CHH) is an autosomal 
recessive disorder of metaphyseal chondrodysplasia 
with multiple systemic manifestations. Dispropor-
tional short-limb dwarfism and sparse brittle hair are 
two of the most prominent features found in CHH 
patients. Other common features include defective 
immunity,1 predisposition to several malignant tu-
mors such as lymphoma,2 ligamentous laxity,3 hypo-
plastic anemia,4 Hirschprung’s disease,5 and impaired 
spermatogenesis.6
Defective immunity has been reported to in-
crease mortality in CHH patients.7 A large number 
of CHH patients have T-cell immunodeficiency, 
which may present as mild to moderate lymphope-
nia, decreased delayed hypersensitivity, and im-
paired in vitro responsiveness of lymphocytes to 
mitogens.8 Humoral immunodeficiency or combined 
immunodeficiency has also been reported in patients 
affected with CHH.9
CHH is caused by mutations in the RNA component 
of mitochondrial RNA processing endoribonuclease 
gene (RMRP) and is transmitted as an autosomal re-
cessive trait.10 The human RMRP is an untranslated, 
intronless 267-base pair (bp) gene, transcribed by 
the DNA-dependent RNA polymerase III. The exact 
pathogenesis of the disease phenotypes is still un-
clear. Only a small number of RMRP mutations have 
been reported in the Oriental population.11,12 In our 
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study, we examined RMRP mutations in a Chinese 
boy with typical CHH and identified one novel 
mutation.
2.  Patient and Methods
A 15-year-old boy was referred to our genetics 
clinic because of failure to thrive, chronic diarrhea, 
complaint of bone pain, and recurrent pulmonary 
infections. The boy’s birth weight was 3210 g (50th−
75th percentile for gestational age), and his length 
was 42 cm (< 10th percentile). Postnatal growth de-
ficiency was observed after the age of 12 months, 
when the first respiratory tract infection developed. 
Since then, he had been suffering from frequent epi-
sodes of recurrent respiratory and gastrointestinal 
infections. At the age of 14 years, his body height 
was 100 cm (−4 SD) and body weight was 18.6 kg 
(−4 SD). A physical examination revealed sparse and 
brittle scalp hair, disproportionate short stature, 
short limbs, genu valgus, lordosis, and generalized 
laxity with limitation of elbow extension. A bone 
radiology examination showed bony scalloping, ir-
regular sclerosis, cystic changes of the widened 
metaphyses, and metaphyseal dysplasia (Figure 1). 
A radiograph of the chest showed mixed alveolar 
and interstitial infiltration over both lungs. A chest 
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Figure 1 Clinical and X-ray characteristics of our 
patient with Cartilage-hair hypoplasia. (A) Photographs 
show a short stature and genu valgus, and (B) brachy-
dactyly of the hands. (C) A radiograph shows cystic 
changes of widened metaphyses and metaphysial dys-
plasia of the patient’s elbow.
computed tomography image showed bronchiectasis 
in both lungs. A lung function test revealed combined 
obstructive and restrictive respiratory dysfunction. 
We did not find growth hormone deficiency or other 
endocrinopathies.
2.1.  Immunological studies
Serum immunoglobulin levels and cellular immune 
assays were measured by nephelometry. Lymphocyte 
proliferation studies were performed by stimula-
tion with phytohemagglutinin antigen (5 μg/mL). 
A nitroblue tetrazolium test and chemotaxis assay 
were performed to assay polymorphonuclear neu-
trophil function.
2.2.  Detection of RMRP mutations
Peripheral blood or hair was obtained with informed 
consent from the patient and his parents. Genomic 
DNA was extracted from peripheral blood leuko-
cytes using standard procedures. A genomic sequence 
of RMRP (M29916: the transcription initiation site 
was designated as + 1) was obtained from a public 
database. Its entire transcribed region and the ap-
proximately 500-bp promoter region were ampli-
fied by polymerase chain reaction (PCR) from 
genomic DNA, and it was screened for mutations 
through direct sequencing. PCR primers used were 
RM3F (5-GGCCAGACCATATTTGCATAAG-3) and RM3R 
(5-CAGTGAGCCGTGGTATCG-3) (− 226 to +295), and 
RM2F (5-GGAGGATACAGGCGAGTCAG-3) and RM2R 
(5-GCAGAATAGCTAATAGACACGAAATG-3) (−548 to 
−148). PCR conditions were 95ºC for 3 minutes, and 
then 35 cycles of 95ºC for 30 seconds, 60ºC for 
30 seconds, 72ºC for 30 seconds, and finally 72ºC 
for 3 minutes. PCR products were sequenced for 
both strands using an ABI Prism 3700 automated 
sequencer (Applied Biosystems, Foster City, CA, 
USA). To confirm mutations on the individual alle-
les, the PCR fragments were subcloned using the 
TGem Easy cloning kit (Invitrogen, Carlsbad, CA, 
USA), and several clones were sequenced using M13 
universal primers.
2.3.  Expression analysis
Total RNAs from peripheral lymphocytes were ex-
tracted using TRIzol reagent (Gibco BRL, Gaithersburg, 
MD, USA) according to the manufacturer’s protocol. 
First-strand cDNAs were synthesized by reverse 
transcription of 5−10 μg of total RNA with 200 U of 
Superscript II RNase H-Reverse transcriptase and a 
gene-specific primer (5-AGCCGCGCTGAGAATGAG-3) 
(248  265). RMRP cDNA (5−257) was amplified using 
the primers RM-RTF (5-GTGCTGAAGGCCTGTATCCT-3) 
and RM-RTR (5-TGAGAATGAGCCCCGTGT-3). PCR 
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conditions were as described above. PCR products 
were analyzed by gel electrophoresis and direct 
sequencing.
3.  Results
3.1.  Hematological and immunological 
studies
Hematological evaluation showed microcytic anemia 
(Hb, 11.5 g/dL; mean corpuscular volume, 74.3 fL), 
leukocytosis (white blood cell count, 13.1 × 109/L) 
and thrombocytopenia (7.5 × 109/L), iron deficiency 
(21 mg/100 mL; normal, 50−150 mg/100 mL), low fer-
ritin (32 ng/mL; normal, 20−200 ng/mL), zinc defi-
ciency (50.2 μg/dL; normal, 100−125 μg/dl), and a 
low calcium level (7.6 mg/dL).
An immunological evaluation showed a deficit 
of both cellular immunity and dysgammaglobuline-
mia. Lymphocyte subsets showed lymphopenia 
(CD3+ T cells: 517 cells/L, 40.62%; CD19+ B cells: 
175 cells/L, 13.72%) but there was a relative in-
crease in natural killer cells (CD56+ cells: 382 cells/L, 
29.98%). A high CD4/CD8 ratio (2.2) contributed to 
relatively low CD8+ cell counts (7.39%). A lower IgG2 
(73.80 mg/dL) was also observed compared with 
age-adjusted reference values of healthy children 
(IgA: 423 mg/dL; IgE: < 18.40 IU/ml; IgM: 49.30 mg/
dL; IgG1: 1493.80 mg/dL; IgG2: 273.80 mg/dL; 
IgG3: 37.95 mg/dL; IgG4: 13.74 mg/dL). Delayed-
type hypersensitivity to Candida antigens (1:10) 
and the results of a tuberculin test (5 TU/0.1 mL) 
were weakly positive. The stimulation index of the 
patient’s lymphocyte proliferation was approxi-
mately 50% of normal controls. Neutrophil func-
tion tests including a chemotaxis assay, nitroblue 
tetrazolium test, and adhesion molecule expression 
were all normal. Levels of C3 and C4 were normal. 
Currently, this patient receives monthly intrave-
nous gamma globulin administration to prevent 
recurrent infections.
3.2.  Detection of RMRP mutations
Two RMRP mutations were found in our patient. 
The paternal mutation is a base substitution of C to T 
at nucleotide +230 (designated as +1 in the tran-
scription initiation site) in the coding sequence of the 
RMRP, similar to that described by Ridanpaa et al.11 
The maternal mutation is a novel mutation that 
consists of a duplication of 14 nucleotides in the 
promoter region of RMRP (g. −26 to −13 dupTAC-
TACTCTGTGAA, promoter region; see Figure 2A).
3.3.  Expression analysis
To confirm that the novel maternal promoter mu-
tation caused the silencing of the corresponding 
RMRP allele,10 we examined the differential allelic 
RMRP expression of our patient with CHH. Direct 
sequencing of the patient’s cDNA showed only the 
paternal C230T allele, suggesting silencing of the 
maternal allele with a promoter mutation. Gel elec-
trophoresis revealed decreased cDNA levels com-
pared with those of both of his parents and a normal 
control (Figure 3A).
4.  Discussion
CHH is one of a few Mendelian disorders caused by 
mutations in a nuclear encoded, noncoding RNA gene. 
The mutations in our patient are compound heter-
ozygote, which has different physiological conse-
quences. The disease-causing functional impairment 
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Figure 2 Mutations found in the patient. (A) A novel 14bp insertional mutation (g. −26 to −13 dupTACTACTCTGTGAA) 
in the patient’s maternal allele is shown. (B) A direct sequencing tract of a normal control is shown.
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of the RMRP product in CHH mutations in humans 
is unknown.11 No obvious genotype-phenotype cor-
relation has been reported to date. RMRP muta-
tions can be classified into two major categories: 
(1) duplications or insertions of some nucleotides 
in the promoter region, and (2) one or two changed 
nucleotides in the transcribed region.11 The muta-
tions found in our patient corresponded to the first 
(maternal mutation) and second (paternal mutation) 
categories. Mutations in the first category have been 
reported to cause silencing of the corresponding 
RMRP alleles, and mutations in the second category 
might cause the alteration of the secondary struc-
ture of the transcripts or alterations in ribosomal 
processing.13
In this study, we have investigated a patient 
with CHH using gene mutation studies and have 
found a new mutation in RMRP (g. −26 to −13 
dupTACTACTCTGTGAA, promoter region). Therefore, 
this enabled the development of a prenatal diagnosis 
for this family.
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Figure 3 Differential expression of parental RMRP alle-
les in the patient. (A) Decreased expression was found 
in our patient by reverse transcriptase polymerase chain 
reaction compared with that in normal control and both 
of his parents. (B) Direct sequencing of RMRP from genomic 
DNA with the 230C > T mutation and (C) cDNA from the 
patient. Only the paternal 230T allele was transcribed. 
(D) Direct sequencing of the same allele from the genomic 
DNA and (E) cDNA from a normal control. N = normal con-
trol; Pat = paternal; Mat = maternal.
